河北医学2017，Vol.23Issue(9)：1493-1495,3.DOI:10.3969/j.issn.1006-6233.2017.09.025
参芪扶正注射液联合化疗治疗肺癌的临床观察
Clinical Observation with Lung Cancer Undergoing Shenqifuzheng Combined Themotherapy
摘要
Abstract
Objective:To investigate the effects of Shenqifuzheng Injection on quality of life and immune function in patients with chemotherapy of lung cancer. Methods:We analyzed 74 cases of lung cancer patients randomly divided into treatment group ( Shen Qi Fu Zheng group ) , positive control group ( Addie injection group) and blank control group. Results:In terms of total effective rate, the treatment group was higher than the blank group, the difference was significant ( P < 0.05) . After treatment, the CD3+, CD4+, CD4+/CD8+and NK cells were no difference between the treatment group and the control group ( P>0.05) , While the con-trol group after treatment, CD3, CD4+, CD8+, CD4+/CD8+ ratio were lower than before treatment ( P<0.05 or P<0.01).After treatment, the CD3+, CD4+, CD4+/CD8+ ratio and the blank control group had statistical significance with the treatment group (P<0.05).Conclusion:Shen Qi Fu Zheng Injection combined with che-motherap can improve the curative effect and the immune function in the lung cancer patients.关键词
参芪扶正注射液/肺癌/化疗/免疫功能Key words
Shen Qi Fu Zheng/Lung cancer/Chemotherapy/Immune function引用本文复制引用
李青山,白璐,高东奇,张晶晶,连相尧,胡潺潺,张振军..参芪扶正注射液联合化疗治疗肺癌的临床观察[J].河北医学,2017,23(9):1493-1495,3.基金项目
2015年河北省承德市科学技术研究与发展计划项目,(编号:2015072) （编号:2015072）
